Human Testing of New Anticancer Therapy Opens at UAB

Lawrence Lamb, an inventor of new cancer therapy set to enter clinical trial at UAB Incysus Therapeutics Inc. has received permission to begin testing a new cancer treatment in patients at the University of Alabama at Birmingham. The new drug-resistant immunotherapy program is based on delivering gamma-delta T cell immunotherapy to…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox